Carboplatin Uses, Side Effects, and More

Carboplatin

Brand name:- Oncocarbin 150mg inj. , Kemocarb150,450 mg/Vail inj. 400mg/m² .

Carboplatin is an anti-cancer medication . It is a less reactive second generation platinum compound that is better tolerated and has a toxicity profile different from Cisplatin.It works by damaging the genetic material (DNA and RNA) of the cancer cells which stops their growth and multiplication.

Pharmacodynamic:-

Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma. Carboplatin has a long duration of action as it is given every weeks, and a narrow therapeutic index. Patients should be counselled regarding bone marrow suppression and anemia.

Pharmacokinetics:-

After a 1 hour infusion of carboplatin, the blood levels of total platinum and free platinum reduce in a biphasic manner. For the free platinum, the first phase of the half life (when the drug achieves half its plasma concentration) is around 90 minutes. In the later phase, the half life is around 6 hours. All free platinum is in the form of carboplatin for the first four hours.

Once administered, the drug binds to plasma proteins. Protein binding is less than with cisplatin. Initially, protein binding is low, with around 29% of the carboplatin bound in the first 4 hours. However, within 24 hours, 85-89% of the platinum in the drug is bound irreversibly to the plasma proteins and is gradually eliminated with a minimum half life of five days.

Carboplatin is excreted via the kidneys. Most of the excretion occurs within the first 6 hours after the drug is administered and around 50% to 60% is excreted within 24 hours. Of all the medication administered, 32% is excreted unchanged in urine.

Mechanism of action:-

Carboplatin undergoes activation inside cells and forms reactive platinum complexes that cause the intra- and inter-strand cross-linkage of DNA molecules within the cell. This modifies the DNA structure and inhibits DNA synthesis. This may affect a cell in all the phases of its cycle.

used:-

Carboplatin is used alone or in combination with other medications to treat cancer of the ovaries (cancer that begins in the female reproductive organs where eggs are formed) that has spread to other parts of the body, not improved, or that has worsened after treatment with other medications or radiation therapy.

sides effects:-

Nausea, Vomiting, Anemia (low number of red blood cells), Low blood platelets, Increased liver enzymes, Decreased white blood cell count (neutrophils), Peripheral neuropathy (tingling and numbness of feet and hand), Diarrhea, Weakness, Hair loss, Taste change, Constipation, Decreased white blood cell count (lymphocytes), Infection, Bleeding, Transfusions, Pain, Sensory disturbance, Central nervous system problems, Visual disturbance, Ototoxicity, Decreased creatinine clearance, Increased creatinine level in blood, Increased blood urea, Increased alkaline phosphatase level in blood, Increased aspartate aminotransferase, Electrolyte imbalance, Hypersensitivity, Skin disorder, Urogenital disorders.

Dose:-

As directed by your doctor.

Cefpodoxime proxetil Uses, Side Effects, and More

Cefpodoxime proxetil Brand name:- cefoprox ,cepodem,DOXCEF 100,200mg cap. Cefpodoxime Proxetil is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive. Pharmacodynamic:- Cefpodoxime is shown to be effective against most Gram positive and Gram negative bacteria, except Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Mechanism of action:- Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime. Cefpodoxime is inactivated by certain extended spectrum beta-lactamases. The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. The active metabolite of cefpodoxime binds preferentially to penicilli

Cephalexin ( ZYD ) ( Cefalexin ) Uses, Side Effects, and More

Cephalexin (ZYD) (Cefalexin) Brand name:- Cephacillin 250,500mg cap; Sporidex, Alcephin,Cephaxin cap. Cephalexin (also called Cefalexin) is the most common used orally effective first generation cephalosporin , similar in spectrum to cefazolin , but less active against penicillinase producing staphylococci and H. Influenza. Plasma protein binding is low; it attains High concentration in bile and is excreted unchanged in urine; t½ - 60min. Pharmacodynamic:- Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations.Label It is effective against most gram-positive bacteria through its inihibition of the cross linking reaction between N-acetyl muramicacid and N-acetylglucosamine in the cell wall, leading to cell lysis. Pharmacokinetics:- Cephalexin is rapidly and almost completely absorbed from t

BASILIXIMAB Uses, Side Effects, and More

BASILIXIMAB BRAND NAME:- Simulect BASILIXIMAB is another anti CD - 25 antibody with higher affinity for the IL-2 receptor, but shorter plasma t½ (1 week) . is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used in combination with other medicines used to prevent organ rejection. PHARMACODYNAMIC:- Basiliximab functions as an IL-2 receptor antagonist. Specifically it inhibits IL-2-mediated activation of lymphocytes, a critical pathway in the cellular immune response involved in allograft rejection. MECHANISM OF ACTION:- Basiliximab competes with IL-2 to bind to the alpha chain subunit of the IL2 receptor on the surface of the activated T lymphocytes and thus prevents the receptor from signaling. This prevents T cells from replicating and also from activating B cells, which are responsible for the production of antibodies, which would bind to the trans

webmedi

Search This Blog